Prosecution Insights
Last updated: October 04, 2026

Kurin Inc.

Technology area: Medical Devices & Mechanical Engineering

5 pending office actions • 1 art units • 3 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Kurin Inc. has 5 pending office actions currently active in the Medical Devices & Mechanical Engineering technology area. These 5 actions are being reviewed by only 3 distinct examiners, showing a narrow distribution of personnel involved in the prosecution process. All of these matters are contained within 1 distinct art unit, which indicates a highly focused technical and procedural environment for the company's patent applications.

The examiner Nguyen, Huong Q is the busiest for this portfolio, handling 3 of the pending office actions. Because 3 out of the 5 total actions are assigned to this single individual, Nguyen, Huong Q's decisions will have a substantial impact on the overall portfolio. The concentration of all 5 actions within 1 distinct art unit suggests that the company can expect a consistent application of examination standards and internal policies across its pending Medical Devices & Mechanical Engineering cases.

For a practitioner, the involvement of only 3 distinct examiners and a single art unit simplifies the coordination of prosecution efforts. However, with Nguyen, Huong Q managing 3 of the 5 pending office actions, the relationship with this specific examiner becomes the primary factor in the portfolio's progress. This centralized prosecution environment in the Medical Devices & Mechanical Engineering sector allows for a more uniform strategy compared to portfolios spread across multiple art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
2
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (40%)
2
Medium (40%)
0
Easy (0%)
1
Unknown (20%)

Rejection Statute Mix

BucketCases
§103 only1 (20%)
Double-patenting + other1 (20%)
Multi-statute (no §101)2 (40%)
No statute on record1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUYEN, HUONG Q 3 45.7% +43.9%
ABOUELELA, MAY A 1 75.3% +36.1%
BAVA, JANKI MAHESH 1 11.1% +50.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18783173 BLOOD SAMPLE OPTIMIZATION DEVICE NGUYEN, HUONG Q —
17696860 BLOOD OPTIMIZATION SET WITH TRANSFER DEVICE BAVA, JANKI MAHESH —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17336178 FLUID OPTIMIZATION AND CONTAMINANT CONTAINMENT DEVICE AND METHOD USING DISPLACEABLE PLUG NGUYEN, HUONG Q 1d overdue
17893079 BLOOD SAMPLE OPTIMIZATION SYSTEM AND BLOOD CONTAMINANT SEQUESTRATION DEVICE AND METHOD NGUYEN, HUONG Q 15d
19643488 BLOOD SAMPLE OPTIMIZATION DEVICE ABOUELELA, MAY A —
18783173 BLOOD SAMPLE OPTIMIZATION DEVICE NGUYEN, HUONG Q —
17696860 BLOOD OPTIMIZATION SET WITH TRANSFER DEVICE BAVA, JANKI MAHESH —

Top Art Units

Art UnitApps
3791 5

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19643488 BLOOD SAMPLE OPTIMIZATION DEVICE ABOUELELA, MAY A 3791 Other Non-Final OA — Pending Apr 09, 2026
18783173 BLOOD SAMPLE OPTIMIZATION DEVICE NGUYEN, HUONG Q 3791 §102§103 Final Rejection — Pending Jul 24, 2024
17893079 BLOOD SAMPLE OPTIMIZATION SYSTEM AND BLOOD CONTAMINANT SEQUESTRATION DEVICE AND METHOD NGUYEN, HUONG Q 3791 §103DP Final Rejection 15d Pending Aug 22, 2022
17696860 BLOOD OPTIMIZATION SET WITH TRANSFER DEVICE BAVA, JANKI MAHESH 3791 §102§103 Non-Final OA — Pending Mar 17, 2022
17336178 FLUID OPTIMIZATION AND CONTAMINANT CONTAINMENT DEVICE AND METHOD USING DISPLACEABLE PLUG NGUYEN, HUONG Q 3791 §103 Final Rejection 1d overdue Pending Jun 01, 2021

Managing Kurin Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month